Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101482155 | 10148215 | 5 | F | 20130827 | 20160921 | 20140501 | 20160926 | PER | US-AMGEN-USASP2014027867 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101482155 | 10148215 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | Y | 1044037 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 101482155 | 10148215 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | Y | 1064414 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 101482155 | 10148215 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 7.5 MG, QWK | 0 | 7.5 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101482155 | 10148215 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101482155 | 10148215 | OT |
| 101482155 | 10148215 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101482155 | 10148215 | Arthropathy | |
| 101482155 | 10148215 | Blood pressure increased | |
| 101482155 | 10148215 | Breast mass | |
| 101482155 | 10148215 | Erythema | |
| 101482155 | 10148215 | Fear of injection | |
| 101482155 | 10148215 | Frequent bowel movements | |
| 101482155 | 10148215 | Hypoaesthesia | |
| 101482155 | 10148215 | Injection site erythema | |
| 101482155 | 10148215 | Injection site macule | |
| 101482155 | 10148215 | Injection site pain | |
| 101482155 | 10148215 | Injection site swelling | |
| 101482155 | 10148215 | Joint destruction | |
| 101482155 | 10148215 | Knee arthroplasty | |
| 101482155 | 10148215 | Mammogram abnormal | |
| 101482155 | 10148215 | Migraine | |
| 101482155 | 10148215 | Mobility decreased | |
| 101482155 | 10148215 | Pain | |
| 101482155 | 10148215 | Paraesthesia | |
| 101482155 | 10148215 | Peripheral coldness | |
| 101482155 | 10148215 | Peripheral swelling | |
| 101482155 | 10148215 | Phobia | |
| 101482155 | 10148215 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101482155 | 10148215 | 1 | 2013 | 0 | ||
| 101482155 | 10148215 | 3 | 2012 | 0 |